Experimental approach reveals how targeted proteins modulate mRNA degradation in unconventional regions, suggesting new methods for gene regulation.
Extensive RNA-protein interactions occur throughout the lifecycle of an mRNA that up- and down-regulate mRNA translation and degradation. Modulating interactions between regulatory proteins and mRNAs can have large effects on gene expression and might be useful for creating therapeutic manipulations, especially for difficult-to-drug proteins. Here, we directed three degradation-inducing proteins that normally bind the 5' cap, 3'-untranslated region (UTR), or 3' poly(A) tail to unconventional sites spanning coding and noncoding regions across a reporter mRNA. DCP2, the 5' decapping enzyme, reduced expression only when targeted to the 5'-UTR. ZFP36L2, a 3'-UTR adapter protein, reduced expression when directed to either the 3'-UTR or the 3' half of the coding sequence, the latter region outside its conventional site. CNOT7, a catalytic subunit within the CCR4-NOT deadenylase complex, reduced expression when directed anywhere in the mRNA, most strongly at both "ends" in the 5'- and 3'-UTRs. mRNAs can therefore be degraded by directing proteins to positions far from their conventionally understood regulatory sites. Our study reveals extensive through-space functional proximity across an mRNA. These observations have broad implications for understanding large-scale RNA structure and for emerging applications in therapeutically targeted RNA degradation.
No takes yet. Share an insight, caveat, or question.
Hatfield et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: